Edition:
United States

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

5.53USD
7 Dec 2016
Change (% chg)

$-0.03 (-0.54%)
Prev Close
$5.56
Open
$5.60
Day's High
$5.60
Day's Low
$5.53
Volume
7,663
Avg. Vol
4,840
52-wk High
$6.00
52-wk Low
$4.20

CPIX.OQ

Chart for CPIX.OQ

About

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcyste... (more)

Overall

Beta: 1.40
Market Cap(Mil.): $89.80
Shares Outstanding(Mil.): 16.18
Dividend: --
Yield (%): --

Financials

  CPIX.OQ Industry Sector
P/E (TTM): -- 30.14 30.77
EPS (TTM): -0.00 -- --
ROI: -0.13 15.85 15.23
ROE: -0.06 16.96 16.56

BRIEF-Cumberland Pharmaceuticals acquires U.S. rights to Nordic Group's methotrexate injection products

* Says it will register and commercialize methotrexate products in United States

Nov 16 2016

BRIEF-Cumberland Pharmaceuticals Q3 earnings per share $0.01

* Cumberland Pharmaceuticals reports third quarter & year to date 2016 financial results

Nov 01 2016

BRIEF-Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S

* Clinigen GrouE and Cumberland Pharmaceuticals launch Rthyol in U.S Source text for Eikon: Further company coverage:

Sep 26 2016

BRIEF-Cumberland reports new program to develop Portaban for Portal Hypertension

* Cumberland Pharmaceuticals announces new program to develop Portaban for Portal Hypertension

Sep 14 2016

BRIEF-Cumberland Pharmaceuticals begins U.S. shipments of Ethyol

* Cumberland Pharmaceuticals begins U.S. shipments of Ethyol(Amifostine) for oncology patient support Source text for Eikon: Further company coverage:

Aug 23 2016

BRIEF-Cumberland Pharmaceuticals posts Q2 adj. earnings $0.04/shr

* Q2 revenue $7.4 million versus $8.9 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Aug 02 2016

BRIEF-Cumberland Pharmaceuticals says Caroline Young to join its board

* Cumberland Pharmaceuticals announces Caroline Young to join its board of directors Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 10 2016

Earnings vs. Estimates